JRCT ID: jRCT2080223625
Registered date:25/08/2017
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 16/08/2017 |
Target sample size | 28 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : concizumab Therapeutic category code : 339 Other agents relating to blood and body fluides Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 634 Human blood preparations Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | efficacy |
---|---|
Secondary Outcome | efficacy |
Key inclusion & exclusion criteria
Age minimum | >= 18age old |
---|---|
Age maximum | Not applicable |
Gender | Male |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT03196284,JapicCTI-173681 |